The majority of patients with CNTN1 antibodies presented with a neuro-renal syndrome characterised by a rapidly progressive, disabling, sensory-motor neuropathy accompanied by typical nephrotic syndrome, with oedema, low serum albumin, and elevated levels of urinary proteinuria. The gene discussed is ALB; the disease is nephrotic syndrome.